Lobe Sciences Ltd. (LOBEF)
Sector: Biotechnology
Industry: Biotechnology
Lobe Sciences Ltd.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 0.0354 | 0.0355 | 0.0354 | 0.0355 | 933 |
| Nov 13, 2026 | 0.0326 | 0.0343 | 0.0320 | 0.0320 | 52,909 |
| Nov 12, 2026 | 0.0291 | 0.0317 | 0.0291 | 0.0317 | 615 |
| Nov 11, 2026 | 0.0280 | 0.0288 | 0.0263 | 0.0271 | 180,854 |
| Nov 10, 2026 | 0.0282 | 0.0287 | 0.0260 | 0.0287 | 46,500 |
| Nov 9, 2026 | 0.0287 | 0.0287 | 0.0261 | 0.0287 | 22,183 |
| Nov 6, 2026 | 0.0243 | 0.0285 | 0.0211 | 0.0267 | 268,233 |
| Nov 5, 2026 | 0.0291 | 0.0291 | 0.0291 | 0.0291 | 15,000 |
| Nov 4, 2026 | 0.0269 | 0.0269 | 0.0265 | 0.0268 | 23,113 |
| Nov 3, 2026 | 0.0293 | 0.0300 | 0.0251 | 0.0300 | 303,700 |
| Nov 2, 2026 | 0.0401 | 0.0401 | 0.0266 | 0.0272 | 26,300 |
| Oct 30, 2026 | 0.0291 | 0.0314 | 0.0290 | 0.0314 | 12,000 |
| Oct 29, 2026 | 0.0375 | 0.0375 | 0.0289 | 0.0289 | 120,100 |
| Oct 28, 2026 | 0.0397 | 0.0397 | 0.0395 | 0.0395 | 22,897 |
| Oct 27, 2026 | 0.0326 | 0.0405 | 0.0326 | 0.0405 | 175,266 |
| Oct 26, 2026 | 0.0275 | 0.0293 | 0.0264 | 0.0293 | 229,956 |
| Oct 23, 2026 | 0.0287 | 0.0287 | 0.0253 | 0.0275 | 47,216 |
| Oct 22, 2026 | 0.0301 | 0.0314 | 0.0257 | 0.0268 | 417,897 |
| Oct 21, 2026 | 0.0355 | 0.0363 | 0.0315 | 0.0363 | 291,977 |
| Oct 20, 2026 | 0.0355 | 0.0355 | 0.0337 | 0.0337 | 35,000 |
Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD).
Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration. This organization, headquartered in Vancouver, Canada, underwent a name change from Greenstar Biosciences Corp. to Lobe Sciences Ltd. in November 2020.
based on 308.18M shares outstanding
30d Avg
109.18K
60d Avg
100.20K
90d Avg
84.05K
Lobe Sciences Ltd. (OTC: LOBEF) traded at $0.0355 on Nov 16, 2026, up 10.81% from the previous close of $0.0320. 52-week range: $0.0207 to $0.1086. The company is in the Healthcare sector (Biotechnology).